Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

被引：32
|
作者：
Woo, Hyun Young
Heo, Jeong [1 ]
机构：
[1] Pusan Natl Univ, Coll Med, Dept Internal Med, 179 Gudeok Ro, Busan 49241, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2015年 / 21卷 / 04期
关键词：
Drug eluting beads; Hepatocellular carcinoma; Transarterial chemoembolization;
D O I：
10.3350/cmh.2015.21.4.344
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
引用
收藏
页码：344 / 348
页数：5
相关论文
共 50 条
  • [31] Contrast-Enhanced Ultrasound Evaluation of Residual Blood Flow to Hepatocellular Carcinoma After Treatment With Transarterial Chemoembolization Using Drug-Eluting Beads A Prospective Study
    Shaw, Colette M.
    Eisenbrey, John R.
    Lyshchik, Andrej
    O'Kane, Patrick L.
    Merton, Daniel A.
    Machado, Priscilla
    Pino, Laura
    Brown, Daniel B.
    Forsberg, Flemming
    JOURNAL OF ULTRASOUND IN MEDICINE, 2015, 34 (05) : 859 - 867
  • [32] D-dimer for assessment of treatment response, and survival to drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma
    Duan, Youjia
    Hou, Xiaopu
    Guo, Jiang
    Li, Honglu
    Cai, Liang
    Cheng, Long
    Zhao, Wenpeng
    Shao, Xihong
    Du, Hongliu
    Diao, Zhenying
    Li, Changqing
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (04)
  • [33] Drug-eluting beads versus conventional transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
    Wang, Zi-Yu
    Xie, Chun-Feng
    Feng, Kun-Liang
    Xiong, Cheng-Ming
    Huang, Jun-Hai
    Chen, Qing-Lian
    Zhong, Chong
    Zhou, Zhai-Wen
    MEDICINE, 2023, 102 (34) : E34527
  • [34] Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug-eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma
    Chen, Shiguang
    Yu, Wenchang
    Zhang, Kongzhi
    Liu, Weifu
    Chen, Chuanben
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 482 - 489
  • [35] Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
    Li, Jinpeng
    Shi, Congcong
    Shi, Jutian
    Song, Jinlong
    Wang, Nan
    MEDICINE, 2021, 100 (44)
  • [36] Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study
    Shi, Qin
    Chen, Dandan
    Zhou, Chen
    Liu, Jiacheng
    Huang, Songjiang
    Yang, Chongtu
    Xiong, Bin
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5461 - 5468
  • [37] Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study
    Chung, Woo-Suk
    Lee, Kwang-Hun
    Park, Mi-Suk
    Lee, Yeo Jin
    Kwon, Joonho
    Baek, Song-Ee
    Kim, Myeong-Jin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 349 - 359
  • [38] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [39] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [40] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
12345